Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues
May 09
Chinese (SSE) Pharma Industry Analysis
UpdatedMay 10, 2024
DataAggregated Company Financials
Companies221
- 7D4.0%
- 3M15.5%
- 1Y-5.0%
- YTDn/a
Over the last 7 days, the Pharma industry has risen 3.1%, driven by gains from Sichuan Biokin PharmaceuticalLtd of 18%. In the same time, Guizhou Bailing Group Pharmaceutical was down 19%. In contrast, the industry has lost 6.2% in the last 12 months. As for the next few years, earnings are expected to grow by 19% per annum.
Industry Valuation and Performance
Has the Chinese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 May 2024 | CN¥2.8t | CN¥821.5b | CN¥77.4b | 32.4x | 36.6x | 3.5x |
| Sun, 07 Apr 2024 | CN¥2.6t | CN¥828.7b | CN¥78.3b | 28.3x | 33.3x | 3.2x |
| Tue, 05 Mar 2024 | CN¥2.6t | CN¥831.7b | CN¥80.8b | 27.7x | 32.5x | 3.2x |
| Thu, 01 Feb 2024 | CN¥2.3t | CN¥831.4b | CN¥80.0b | 24.6x | 29.1x | 2.8x |
| Sat, 30 Dec 2023 | CN¥2.8t | CN¥827.8b | CN¥79.7b | 31x | 35.3x | 3.4x |
| Mon, 27 Nov 2023 | CN¥2.9t | CN¥819.4b | CN¥78.7b | 32.4x | 37.1x | 3.6x |
| Wed, 25 Oct 2023 | CN¥2.6t | CN¥825.4b | CN¥78.7b | 30.1x | 33.5x | 3.2x |
| Fri, 22 Sep 2023 | CN¥2.7t | CN¥824.6b | CN¥78.5b | 30.5x | 34.4x | 3.3x |
| Sun, 20 Aug 2023 | CN¥2.6t | CN¥815.0b | CN¥77.6b | 31.2x | 34x | 3.2x |
| Tue, 18 Jul 2023 | CN¥2.8t | CN¥811.0b | CN¥76.9b | 31.2x | 36.3x | 3.4x |
| Thu, 15 Jun 2023 | CN¥2.8t | CN¥809.7b | CN¥76.5b | 32.3x | 37x | 3.5x |
| Sat, 13 May 2023 | CN¥2.9t | CN¥808.3b | CN¥76.4b | 32.7x | 38.3x | 3.6x |
| Mon, 10 Apr 2023 | CN¥3.0t | CN¥796.3b | CN¥89.8b | 33.9x | 33.4x | 3.8x |
| Wed, 08 Mar 2023 | CN¥3.0t | CN¥777.6b | CN¥83.3b | 36.8x | 35.6x | 3.8x |
| Fri, 03 Feb 2023 | CN¥3.0t | CN¥773.8b | CN¥83.3b | 36.4x | 35.4x | 3.8x |
| Sun, 01 Jan 2023 | CN¥2.7t | CN¥771.4b | CN¥82.1b | 34x | 33x | 3.5x |
| Tue, 29 Nov 2022 | CN¥2.8t | CN¥767.8b | CN¥81.9b | 36.5x | 33.7x | 3.6x |
| Thu, 27 Oct 2022 | CN¥2.6t | CN¥754.2b | CN¥81.0b | 34.1x | 32.4x | 3.5x |
| Sat, 24 Sep 2022 | CN¥2.3t | CN¥760.3b | CN¥79.5b | 29.4x | 29.2x | 3.1x |
| Mon, 22 Aug 2022 | CN¥2.6t | CN¥753.9b | CN¥81.4b | 30.8x | 31.9x | 3.4x |
| Wed, 20 Jul 2022 | CN¥2.7t | CN¥744.9b | CN¥81.0b | 31x | 33.5x | 3.6x |
| Fri, 17 Jun 2022 | CN¥2.7t | CN¥739.6b | CN¥82.0b | 31.7x | 32.5x | 3.6x |
| Sun, 15 May 2022 | CN¥2.7t | CN¥740.2b | CN¥81.7b | 33.5x | 32.6x | 3.6x |
| Tue, 12 Apr 2022 | CN¥2.7t | CN¥724.6b | CN¥76.6b | 33.1x | 35.2x | 3.7x |
| Thu, 10 Mar 2022 | CN¥2.7t | CN¥726.6b | CN¥77.5b | 31.2x | 34.4x | 3.7x |
| Sat, 05 Feb 2022 | CN¥2.7t | CN¥721.5b | CN¥73.6b | 32.1x | 37.2x | 3.8x |
| Mon, 03 Jan 2022 | CN¥3.2t | CN¥720.5b | CN¥73.8b | 38.5x | 43.4x | 4.4x |
| Wed, 01 Dec 2021 | CN¥3.0t | CN¥717.1b | CN¥73.0b | 32x | 41.4x | 4.2x |
| Fri, 29 Oct 2021 | CN¥2.8t | CN¥715.2b | CN¥74.0b | 28.5x | 37.6x | 3.9x |
| Sun, 26 Sep 2021 | CN¥2.8t | CN¥702.7b | CN¥71.2b | 31.8x | 39.9x | 4x |
| Tue, 24 Aug 2021 | CN¥2.8t | CN¥702.6b | CN¥71.1b | 29.9x | 39.6x | 4x |
| Wed, 30 Jun 2021 | CN¥3.2t | CN¥697.2b | CN¥70.2b | 32.4x | 46.1x | 4.6x |
Price to Earnings Ratio
46.6x
Current Industry PE
- Investors are relatively neutral on the Chinese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 36.0x.
- The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 3.6% per year over the last three years.
- Revenues for these companies have grown 6.5% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Chinese Pharma compare with similar industries?
| CN Market | 2.17% | |
| Healthcare | 3.88% | |
| Pharma | 3.98% | |
| Pharma | 3.98% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688506 Sichuan Biokin PharmaceuticalLtd | CN¥183.02 | 18.3% +CN¥11.4b | 77.7% | PE16.7x | |
| 600276 Jiangsu Hengrui Medicine | CN¥46.90 | 1.6% +CN¥4.7b | 1.0% | PE67.3x | |
| 600085 Beijing Tongrentang | CN¥44.70 | 5.6% +CN¥3.3b | -22.4% | PE35.6x | |
| 661 Changchun High-Tech Industry (Group) | CN¥119.22 | 5.4% +CN¥2.5b | -25.8% | PE10.6x | |
| 688166 BrightGene Bio-Medical Technology | CN¥36.20 | 16.8% +CN¥2.2b | 70.2% | PE76.2x |
